Article

Prognostic and Therapeutic Implications of Measurable Residual Disease Detection Across Hematologic Malignancies: Clinical Impact on Relapse Prediction and Survival Outcomes

2026-05-28

Abstract excerpt

<title>Abstract</title> <p>Measurable residual disease (MRD) status has become the most powerful predictive factor in hematologic cancers and has questioned the sufficiency of morphologic complete remission. The purpose of this study is to evaluate the diagnostic and therapeutic value of MRD status in terms of its predictive capacity for relapse and impact on Overall Survival (OS) and Progression-Free Survival (P...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f76487ef-b40a-5422-ad09-7328dd36b5cf
DOI: 10.21203/rs.3.rs-9817780/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Prognostic and Therapeutic Implications of Measurable Residual Disease Detection Across Hematologic Malignancies: Clinical Impact on Relapse Prediction and Survival OutcomesDOI 10.21203/rs.3.rs-9817780/v1Read

Real-World Outcomes in NPM1-Mutated Acute Myeloid Leukemia: The Impact of Measurable Residual Disease on Disease Relapse.Semantic proximity Read

Minimal Residual Disease Detection in Acute Lymphoblastic LeukemiaSemantic proximity Read

Current strategies for detection and approach to measurable residual disease in acute myeloid leukemia.Semantic proximity Read

Minimal Residual Disease in Oncology: From Cure to Longitudinal Patient ManagementSemantic proximity Read

Significance of Measurable Residual Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid LeukemiaSemantic proximity Read

Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemiaSemantic proximity Read

Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell TransplantationSemantic proximity Read

Molecular Measurable Residual Disease Assessment before Hematopoietic Stem Cell Transplantation in Pediatric Acute Myeloid Leukemia Patients: A Retrospective Study by the I-BFM Study GroupSemantic proximity Read

Measurable residual disease monitoring by NGS before allogeneic hematopoietic cell transplantation in AML.Semantic proximity Read

Measurable residual disease testing in acute myeloid leukemia: current state, foundational models, and tools for future development.Semantic proximity Read

Validation Study of Analytical Methods for Multiparameter Flow Cytometry-Based Measurable Residual Disease Assessment in Acute Myeloid LeukemiaSemantic proximity Read

Minimal residual disease in acute myelogenous leukemia.Semantic proximity Read